Abstract 2135: QLS4131, a proprietary T cell engager targeting both BCMA and GPRC5D for the treatment of multiple myeloma

Authors: Liuqing Yang, Hongliang Qian, Juan Luo, Ke Liu, Ling Zhang, Shuyong Zhao, Hua Ying, Weikang Tao

Published: 2025-04-21

DOI: 10.1158/1538-7445.am2025-2135

Source: Full article